stroke
global
health
concern
lead
perman
disabl
approxim
survivor
weinstein
koerner
devast
complic
aris
either
sudden
loss
blood
suppli
brain
ischem
stroke
ruptur
blood
vessel
brain
hemorrhag
stroke
deb
sharma
hassan
stroke
lead
induct
inflammatori
cascad
via
migrat
activ
microglia
ischem
core
worsen
outcom
perera
et
al
narrow
therapeut
window
insuffici
recov
protect
die
neuron
certain
limit
current
treatment
strategi
stroke
urgent
need
altern
approach
fann
et
al
kaur
et
al
limit
improv
aggrav
inflammatori
condit
current
use
thrombolyt
agent
necessit
newer
treatment
option
stroke
carrol
known
immunomodulatori
properti
explor
improv
condit
stroke
mark
play
role
agent
sever
immun
cascad
significantli
help
obviat
condit
central
nervou
system
improv
pathogenesi
mani
neurolog
condit
report
suggest
role
decreas
neuron
cell
death
increas
function
recoveri
attenu
inflamm
stroke
onset
kuo
et
al
broadli
express
cytokin
approv
us
fda
past
multipl
sclerosi
rrm
treatment
decad
kuo
et
al
drive
innat
immun
act
respons
pathogen
attack
injuri
via
activ
cytokin
current
research
conduct
find
protect
role
sever
diseas
ischem
stroke
subarachnoid
hemorrhag
coliti
colorect
cancer
kotred
thoma
gamero
kuo
et
al
tiebosch
et
al
along
condit
tabl
kuo
et
al
antivir
krau
oschmann
samuel
immuno
modulatori
kasper
reder
dierckx
et
al
friedman
cell
differenti
krau
oschmann
see
tabl
neurodegener
mostli
trigger
numer
inflammatori
mediat
lead
neurolog
patholog
includ
ischem
stroke
zipp
akta
inflamm
initi
releas
variou
inflammatori
mediat
activ
intravascular
leukocyt
help
infiltr
immun
cell
cn
anrath
iadecola
kieseier
immun
cell
migrat
across
barrier
bbb
caus
breakdown
bbb
due
releas
numer
cytotox
agent
like
cytokin
matrix
metalloproteinas
nitric
oxid
reactiv
oxygen
speci
ro
lead
demyelin
axon
injuri
common
outcom
neurodegener
kuo
et
al
although
damag
caus
neuron
repar
immunomodulatori
therapi
report
decreas
inflamm
markowitz
polypeptid
produc
fibroblast
attach
specif
receptor
initi
complex
transcript
reaction
produc
pharmacolog
respons
site
injuri
markowitz
report
help
suppress
antigen
present
decreas
cell
prolifer
alter
cytokin
matrix
metalloproteinas
express
kieseier
markowitz
help
elev
concentr
express
agent
cytokin
express
kuo
et
al
system
applic
may
reduc
increas
cell
count
inflammatori
cell
across
bbb
help
rais
nerv
growth
factor
ngf
level
ultim
result
dramat
increas
surviv
neuron
kieseier
may
also
help
rais
natur
killer
cell
count
cell
produc
mediat
effici
capac
mitig
neuron
inflamm
peripher
blood
circul
variou
mechanist
approach
manifest
clinic
relev
reduc
lesion
decreas
risk
sustain
disabl
progress
decreas
brain
atrophi
kieseier
cerebr
ischemia
respons
produc
variou
immun
cell
mediat
exacerb
ischem
brain
injuri
variou
inflammatori
mediat
certain
situat
may
induc
toler
cerebr
ischemia
mediat
like
proinflammatori
cytokin
exampl
interleukin
tumor
necrosi
factor
tnf
molecular
pattern
damp
respons
activ
intracellular
signal
pathway
mediat
stress
respons
anrath
iadecola
immun
cell
therapi
highli
explor
preclin
also
clinic
set
variou
acut
injuri
relat
cn
includ
stroke
bang
georg
steinberg
immunomodulatori
help
regul
function
immun
cell
ischem
stroke
modul
antigen
present
cell
apc
reduc
antigen
present
stimul
cell
jiang
et
al
directli
affect
cell
inhibit
adhes
molecul
like
intercellular
adhes
molecul
icam
vascular
adhes
molecul
vcam
bbb
passag
mark
b
cell
secret
inflammatori
mediat
respons
stimul
plasma
cell
produc
immunoglobulin
ig
cerebrospin
fluid
csf
dalaka
b
cell
activ
factor
baff
belong
tnf
famili
upregul
blood
krumbholz
et
al
crucial
maintain
b
cell
level
inflamm
site
aggrav
local
inflamm
facilit
b
cell
surviv
krumbholz
et
al
modul
function
alter
antigen
present
express
mhc
ii
b
cell
reduc
help
decreas
express
inhibit
antigen
present
cell
dona
reder
jiang
et
al
treatment
result
upregul
express
b
cell
contribut
reduct
type
helper
cell
secret
inflammatori
cytokin
huang
ito
dangond
level
baff
also
upregul
blood
leukocyt
serum
therapi
show
elev
b
cell
function
krumbholz
et
al
correct
combin
stimuli
lead
increas
b
cell
secret
cytokin
like
suggest
increas
regulatori
cell
along
regulatori
b
cell
meinl
krumbholz
hohlfeld
cell
death
follow
brain
ischemia
mediat
divers
group
etiolog
sever
focal
hypoperfus
eventu
result
excitotox
oxid
damag
lakhan
kirchgessn
hofer
event
respons
caus
microvascular
injuri
bbb
dysfunct
elicit
inflamm
ischemia
event
kind
worsen
primari
injuri
may
result
sever
cerebr
damag
extent
perman
cerebr
damag
reli
upon
differ
factor
ischem
durat
infarct
volum
along
capabl
brain
dirnagl
iadecola
moskowitz
lakhan
et
al
respons
inflammatori
cascad
worsen
cerebr
injuri
interest
target
therapeut
inflamm
increas
time
strongli
involv
exacerb
neuron
outcom
jin
yang
li
report
system
appli
help
attenu
brain
infarct
progress
veldhui
et
al
phase
ischemia
resid
microgli
cell
mg
peripher
inflammatori
cell
infiltr
surround
core
region
infarct
area
brain
lead
secondari
neurodegener
weinstein
et
al
onset
ischemia
mainli
link
extravas
protein
bioactiv
phospholipid
bbb
disrupt
prompt
resid
mg
activ
infiltr
ischem
site
multifari
event
lead
activ
cytokin
like
chemokin
motif
ligand
chemokin
motif
ligand
endogen
releas
injuri
site
culmin
neuron
death
dene
thornton
rothwel
allan
weinstein
et
al
sinc
discoveri
ifn
ifn
progress
poorli
understood
antivir
substanc
treatment
five
disord
baron
et
al
discuss
variou
mechan
therapeut
potenti
howev
certain
side
effect
limit
use
pestka
although
usual
safe
well
toler
caus
certain
advers
effect
ifn
caus
local
advers
event
system
advers
reaction
well
goebel
treatment
patient
exhibit
fatigu
myalgia
headach
malais
joint
pain
pestka
depress
report
patient
prior
psychiatr
histori
follow
therapi
fragoso
et
al
reduc
dose
elicit
sever
depress
alter
toler
result
discontinu
treatment
asni
de
la
garza
ii
studi
demonstr
endogen
molecul
like
melatonin
potent
antioxid
regul
circadian
rhythm
mayb
help
mitig
depress
symptom
associ
hansen
danielsen
hageman
rosenberg
also
report
therapi
combin
folat
methionin
vari
degre
outcom
monotherapi
augment
therapi
depress
franscina
pinto
andrad
howev
till
date
studi
examin
therapeut
treatment
depress
disord
therefor
apprais
possibl
futur
studi
thu
therapi
may
serv
substanti
therapi
treatment
acut
ischem
stroke
side
effect
reduc
prevent
inflamm
immun
essenti
fundament
part
pathogenesi
initi
ischem
reperfus
injuri
inflammatori
cascad
respons
initi
earli
molecular
event
caus
due
blood
vessel
occlus
culmin
brain
invas
variou
inflammatori
cell
cn
inflamm
cytotox
bbb
disrupt
peripher
immun
cell
infiltr
injuri
site
play
import
role
secondari
brain
injuri
lead
increas
brain
infarct
may
play
protect
multiphas
role
ischem
stroke
review
focus
neuroprotect
role
ischem
stroke
grow
bodi
evid
indic
inflammatori
mediat
predominantli
deleteri
primari
phase
ischem
stroke
may
promis
treatment
option
ischem
stroke
may
salutari
futur
adjuv
therapi
preclin
find
enter
clinic
level
therapeut
agent
ischem
stroke
howev
substanti
find
requir
carri
futur
better
understand
ischem
stroke
relat
cn
inflamm
cytotox
bbb
dysfunct
therapeut
potenti
ischem
stroke
author
conflict
interest
declar
conceptu
mw
hk
ds
pb
methodolog
mw
hk
ds
pb
write
origin
draft
hk
ds
js
kp
kv
kk
ab
dy
kd
pb
visual
mw
hk
ds
dy
kd
ab
pb
write
review
edit
mw
hk
ds
js
ab
kk
kd
pb
